Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly ...
Read more
Considerations for RT-qPCR in molecular point of care testing devices
The COVID-19 pandemic has accelerated the uptake of point of care testing (POCT), with simple, user-administered tests becoming commonplace in schools, places of work and people’s homes. Antigen POCT has been pivotal in SARS-CoV-2 detection, particularly where reverse transcription PCR (RT-PCR) cannot be delivered in a timely manner. However, the use of antigen tests isn’t always appropriate due to variable sensitivity. RT-PCR – or RT-qPCR if using real-time detection – offers greater sensitivity and specificity. Leveraging this technology in POCT brings lab quality results to the point of need, providing rapid, accurate and actionable results to clinicians.
Read moreThe BiosearchTech Blog
The FDA has awarded Biosearch Technologies a five year contract for the development of multiplexed, fluorescent ...
Read more
Topics: Molecular Diagnostics, Custom Oligos, Food Safety, Biodefense